Abstract
This study assessed the effects of saponins and extract of S. mombin on insulin signaling pathway and glucose metabolism related genes (IR-Insulin Receptor, AKT-protein kinase B, PPAR-γ- Peroxisome Proliferator activated receptor Gamma, DPP-4- Dipeptidyl peptidases 4) in high-fat diet (HFD) and streptozotocin (STZ)-induced T2DM rats, aiming to validate its ethnomedicinal use and elucidate gene-modulating potential. Male Wistar rats (150-200 g) were acclimatized, then divided into five groups (n=6): Group 1: normal control, Group 2: positive control, Group 3: diabetic control, Group 4: 200mg/kg of saponins and Group 5: 400mg/kg of extract. T2DM was induced by a combination of high fat diet followed by low-dose STZ (35 mg/kg.). Treatments were administered orally for 2 weeks. Body weights and organ weights (pancreas, liver) were measured. Liver RNA was isolated for semi-quantitative RT-PCR analysis. The result obtained showed that diabetes resulted in significant reduction in body weight, pancreas weight and reduced expression of IR, AKT, GLUT-4, PPAR-γ, and of DPP-4 as seen in the diabetic control. Treatment of the diabetic rats with glipizide, saponins and ethanol extract of S mombin leaves improved the expression of these genes when compared with the untreated diabetic rats. The comparable performance of the isolated saponins to the crude extract strongly implies that saponins are a principal phytoconstituent responsible for the plant’s insulin-sensitizing and antidiabetic activities. These findings provide solid molecular evidence supporting the ethnopharmacological use of S. mombin in managing type 2 diabetes.
Keywords:Type 2 diabetes, Spondias mombin, Saponins, High fat diet, Gene expression
Comments: no replies